In this issue:
A blended digital intervention for relapse prevention in schizophrenia
Comparative effectiveness of AP monotherapy and polypharmacy in schizophrenia patients with clozapine treatment
Course of cognitive ability in individuals with psychotic disorders
AP utilisation trajectories three years after initiating or reinitiating treatment of schizophrenia
Educational attainment and mortality in schizophrenia
Mortality in people with schizophrenia: relative risk and attenuating factors
Oral and long-acting APs for relapse prevention in schizophrenia-spectrum disorders
Optimal doses of specific APs for relapse prevention in schizophrenia
Acute + maintenance ECT vs clozapine on psychopathology and regional cerebral blood flow in TRS
Probiotics + dietary fibre attenuate olanzapine-induced weight gain in drug-naïve first-episode schizophrenia
Please login below to download this issue (PDF)